Clovis Oncology Revenue 2010-2021 | CLVS

Clovis Oncology revenue from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Clovis Oncology Annual Revenue
(Millions of US $)
2020 $165
2019 $143
2018 $95
2017 $56
2016 $0
2015 $
2014 $14
2013 $
2012 $
2011 $
2010 $
2009 $
Clovis Oncology Quarterly Revenue
(Millions of US $)
2021-06-30 $37
2021-03-31 $38
2020-12-31 $43
2020-09-30 $39
2020-06-30 $40
2020-03-31 $43
2019-12-31 $39
2019-09-30 $38
2019-06-30 $33
2019-03-31 $33
2018-12-31 $30
2018-09-30 $23
2018-06-30 $24
2018-03-31 $19
2017-12-31 $17
2017-09-30 $17
2017-06-30 $15
2017-03-31 $7
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2014-03-31 $14
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2009-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.513B $0.165B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76